RCG
APTO

Rock Creek Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Rock Creek Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150
Closed -$147K – 230
2021
Q3 		$147K Sell
150
-339
-69% -$424K 0.02% 120
2021
Q2 		$731K Buy
489
+67
+16% +$146K 0.11% 75
2021
Q1 		$1.14M Sell
422
-256
-38% -$508K 0.19% 59
2020
Q4 		$1.34M Buy
678
+104
+18% +$244K 0.55% 51
2020
Q3 		$1.55M Buy
574
+218
+61% +$544K 0.8% 35
2020
Q2 		$1.01M Sell
356
-177
-33% -$571K 0.54% 43
2020
Q1 		$1.43M Buy
533
+276
+107% +$823K 0.79% 39
2019
Q4 		$655K Buy
257
+57
+29% +$74.3K 0.26% 84
2019
Q3 		$187K Sell
200
-17
-8% -$19.4K 0.09% 101
2019
Q2 		$255K Buy
+217
New +$200K 0.12% 100

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Rock Creek Group's APTO Position: Q4 2021 in Review

Rock Creek Group sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 150 shares — an estimated $147K sold.

Rock Creek Group first reported a position in APTO in Q2 2019 and held it in 10 quarters. The position peaked at $1.55M in Q3 2020. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • Rock Creek Group reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Rock Creek Group sold 150 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $147K.
  • Rock Creek Group first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 10 quarters.
  • Rock Creek Group's Aptose Biosciences, Inc. position peaked at $1.55M in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Rock Creek Group's 13F filing for Q4 2021, filed 11 Feb 2022.